[Activity of benzamide and it's derivatives against botulinum intoxication].
Ugriumova
G A
GA
Laboratory of Clostridioses, NII of Epidemiology and Microbiology, RAMN, Moscow.
Krasil'nikov
I I
II
Alferova
O F
OF
Vinogradova
I D
ID
Vertiev
I V
IV
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000633:toxicity; D001906:Botulism / Q000139:chemically induced / Q000188:drug therapy* / Q000401:mortality; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005500:Follow-Up Studies; D008297:Male; D051379:Mice; D009465:Neuromuscular Agents / Q000633:toxicity; D015996:Survival Rate; D016896:Treatment Outcome
D000998:Antiviral Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D009465:Neuromuscular Agents; C088105:3-(N-butyrylamino)benzamide; C037689:benzamide; C025160:3-aminobenzamide; D019274:Botulinum Toxins, Type A